Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valeur Pronostique Dans Une Population d'Amylose Cardiaque Des paramètres échocardiographiques basée Sur Une Approche d'Apprentissage Automatique

NCT05772091 is registered in ClinicalTrials.gov with Pr. Nicolas GIRERD as lead sponsor.

NCT NCT05772091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05772091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valeur Pronostique Dans Une Population d'Amylose Cardiaque Des paramètres échocardiographiques basée Sur Une Approche d'Apprentissage Automatique
Lead sponsor
Pr. Nicolas GIRERD
Phase
Observational
Overall status
Unknown status
Start date
September 29, 2023
Completion date
March 31, 2024
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin cardiac amyloidosis